Revised earnings forecast for the fiscal year ending September 2026. Revenue increased from the previous forecast of 332 million to 442 million yen; operating income improved from \u25b31,018 million to \u25b3800 million; ordinary income from \u25b31,018 million to \u25b3796 million; net income attributable to owners of parent from \u25b31,020 million to \u25b3799 million, all revisions upward. The changes are due to revenue recognition from new contracts and timing differences in costs.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4884","jir_company_name":"Clinglea Phama Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4884-20260916-02.pdf","jir_short_summary":"Revised earnings forecast for the fiscal year ending September 2026. Revenue increased from the previous forecast of 332 million to 442 million yen; operating income improved from \u25b31,018 million to \u25b3800 million; ordinary income from \u25b31,018 million to \u25b3796 million; net income attributable to owners of parent from \u25b31,020 million to \u25b3799 million, all revisions upward. The changes are due to revenue recognition from new contracts and timing differences in costs.","jir_summary":"### Key points of earnings forecast revision\nThe revised earnings forecast for the fiscal year ending September 2026, announced today, increases revenue while improving most profit metrics by accounting for timing differences in costs. A transient revenue recognition of 1 hundred million yen from new contracts and timing mismatches in development costs are the primary factors driving the changes.\n\n### Outlook and risks\nActual results may differ from the revised forecast depending on contract execution status, market environment, and timing of development costs. Also, earnings per share are expected to improve due to changes in the number of shares outstanding during the period.","jir_financial_highlights":"Revenue: Previous forecast (A) 332 million yen \/ Current revised forecast (B) 442 million yen (Increase of 110 million yen \/ 33.1% increase)\nOperating income: Previous forecast (A) \u25b31,018 million yen \/ Current revised forecast (B) \u25b3800 million yen (Improvement of 218 million yen)\nOrdinary income: Previous forecast (A) \u25b31,018 million yen \/ Current revised forecast (B) \u25b3796 million yen (Improvement of 222 million yen)\nNet income attributable to owners of parent: Previous forecast (A) \u25b31,020 million yen \/ Current revised forecast (B) \u25b3799 million yen (Improvement of 221 million yen)\nEarnings per share: Previous forecast (A) \u25b3139.85 yen \/ Current revised forecast (B) \u25b3103.52 yen (Improvement approximately 36.33 yen)","jir_category":"","jir_hashtags":"#ClingleaPharma, #EarningsRevision","jir_key_figures":"Revenue: 442 million yen (previous forecast 332 million yen)\nOperating income: \u25b3800 million yen (previous forecast \u25b31,018 million yen)\nOrdinary income: \u25b3796 million yen (previous forecast \u25b31,018 million yen)","jir_meta_title":"\u3010ClingleaPharma\u3011Fiscal Year Ending September 2026 Earnings Forecast Revision | Revenue Increase and Profit Improvement","jir_meta_description":"ClingleaPharma revises its earnings forecast for the fiscal year ending September 2026. Revenue expected at 442 million yen, operating income at \u25b3800 million yen, net income at \u25b3799 million yen. The revision is driven by revenue recognition from new contracts and cost timing differences.","jir_og_title":"ClingleaPharma 2026 Fiscal Year Earnings Forecast Revision","jir_og_description":"ClingleaPharma revises its earnings forecast for the fiscal year ending September 2026. Revenue increased and profits are expected to improve. Revenue recognition from new contracts is a key factor.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60827,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-114617","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n